Medistri is pleased to announce its official membership in Swiss Medtech, the leading association representing the Swiss MedTech industry. This membership marks an important step in strengthening Medistri’s active participation within the Swiss healthcare and MedTech ecosystem.
Strengthening Our Position in the Swiss MedTech Landscape
Swiss Medtech represents companies across the entire MedTech value chain in Switzerland, from innovation and development to manufacturing, regulatory strategy, and market access.
By joining this network, Medistri reinforces its long-term commitment to:
- Supporting medical device manufacturers with compliant infrastructure.
- Contributing to industry dialogue and regulatory evolution.
- Remaining closely aligned with Swiss and European regulatory developments.
- Strengthening collaboration within the national healthcare ecosystem.
As a Swiss-based infrastructure partner operating across Switzerland and Hungary, Medistri provides integrated services including sterilization, laboratory testing, packaging validation, manufacturing, logistics and regulatory support. Active engagement within Swiss Medtech further enhances our ability to anticipate industry needs and evolving compliance requirements.
A Shared Commitment to Healthcare Innovation
Switzerland remains one of the world’s most dynamic hubs for MedTech innovation. Participation in Swiss Medtech enables Medistri to:
- Engage with industry peers and policymakers
- Contribute to discussions shaping regulatory and quality frameworks
- Support sustainable growth within the Swiss MedTech sector
This membership supports Medistri’s continued engagement in the Swiss MedTech environment in which healthcare manufacturers develop, scale, and operate.
About Swiss Medtech
Swiss Medtech is the association of the Swiss medical technology industry. It represents companies of all sizes and supports favorable regulatory, political, and economic conditions for the MedTech sector in Switzerland.
We thank Swiss Medtech for welcoming Medistri into the association and look forward to contributing to the ongoing development of Switzerland’s MedTech sector.
Learn more about Medistri’s role in the healthcare industry in our website here or contact us at contact@medistri.com.
– The Medistri Team
#Medistri
Medistri is Europe's leading independent contract sterilization company, founded in 2006 and headquartered in the heart of Switzerland. We are a global player providing essential infrastructure that powers healthcare innovation worldwide.
We serve customers of all sizes, from startups, university projects, and research institutes to Fortune 500 corporations, across Medical Devices, Pharmaceutical Packaging, and Biotech.
Medistri supports products at every stage of the lifecycle: pre-clinical development, go-to-market, and full industrialization.
Our fully integrated, end-to-end in-house solution allows our customers to focus on what matters most: engineering, innovation, and development, while we manage the critical back-end processes.
Our synchronized departments work together to provide a complete stack of services:
- Contract Sterilization & Validation Services
- Contract Laboratory Services
- Contract Manufacturing Services
- Logistics Services
- Consulting Services
We help you accelerate time-to-market, reduce barriers to scale, and deliver safer, more sustainable healthcare solutions to patients around the world.
Frequently Asked Questions
1. What is Swiss Medtech and what role does it play in Switzerland?
- Swiss Medtech is the leading association representing the Swiss medical technology industry. It supports companies across the value chain by engaging in regulatory dialogue, policy discussions, and initiatives that strengthen the national MedTech ecosystem.
2. Why is Medistri’s membership in Swiss Medtech significant?
- Membership reflects active participation within the Swiss MedTech landscape rather than passive industry observation. It reinforces engagement in regulatory developments, industry discussions, and collaborative initiatives that shape the healthcare environment in Switzerland.
3. How does industry association membership benefit medical device manufacturers?
- Participation in industry networks promotes alignment with evolving regulatory expectations and emerging sector trends. It also facilitates dialogue between infrastructure providers, manufacturers, and policymakers, contributing to a more coordinated and predictable regulatory framework.
4. When does industry engagement become strategically important for infrastructure partners?
- Industry engagement becomes particularly important as regulatory complexity increases and cross-border coordination expands. Active participation supports better anticipation of compliance changes and evolving market expectations.
5. How does Medistri integrate its Swiss Medtech membership into its service model?
- Medistri leverages its participation in Swiss Medtech to remain closely aligned with regulatory and industry developments. By combining this engagement with its integrated sterilization, laboratory, manufacturing, logistics, and regulatory services, Medistri supports manufacturers operating within the Swiss and European MedTech landscape.